Chargement en cours...
The B-cell receptor signaling pathway as a therapeutic target in CLL
Targeted therapy with imatinib and other selective tyrosine kinase inhibitors has transformed the treatment of chronic myeloid leukemia. Unlike chronic myeloid leukemia, chronic lymphocytic leukemia (CLL) lacks a common genetic aberration amenable to therapeutic targeting. However, our understanding...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3418714/ https://ncbi.nlm.nih.gov/pubmed/22715122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-362624 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|